These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 31554638

  • 1. A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells.
    Jung K, Kim JA, Kim YJ, Lee HW, Kim CH, Haam S, Kim YS.
    Cancer Immunol Res; 2020 Jan; 8(1):46-56. PubMed ID: 31554638
    [Abstract] [Full Text] [Related]

  • 2. Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis.
    Kim YJ, Bae J, Shin TH, Kang SH, Jeong M, Han Y, Park JH, Kim SK, Kim YS.
    J Control Release; 2015 Oct 28; 216():56-68. PubMed ID: 26260451
    [Abstract] [Full Text] [Related]

  • 3. Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity.
    Overacre-Delgoffe AE, Chikina M, Dadey RE, Yano H, Brunazzi EA, Shayan G, Horne W, Moskovitz JM, Kolls JK, Sander C, Shuai Y, Normolle DP, Kirkwood JM, Ferris RL, Delgoffe GM, Bruno TC, Workman CJ, Vignali DAA.
    Cell; 2017 Jun 01; 169(6):1130-1141.e11. PubMed ID: 28552348
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cancer Exacerbates Ischemic Brain Injury Via Nrp1 (Neuropilin 1)-Mediated Accumulation of Regulatory T Cells Within the Tumor.
    Wang L, Zhou Y, Yin J, Gan Y, Wang X, Wen D, Thomson AW, Hu X, Yang L, Stetler RA, Li P, Yu W.
    Stroke; 2018 Nov 01; 49(11):2733-2742. PubMed ID: 30355201
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy.
    Van Damme H, Dombrecht B, Kiss M, Roose H, Allen E, Van Overmeire E, Kancheva D, Martens L, Murgaski A, Bardet PMR, Blancke G, Jans M, Bolli E, Martins MS, Elkrim Y, Dooley J, Boon L, Schwarze JK, Tacke F, Movahedi K, Vandamme N, Neyns B, Ocak S, Scheyltjens I, Vereecke L, Nana FA, Merchiers P, Laoui D, Van Ginderachter JA.
    J Immunother Cancer; 2021 Feb 01; 9(2):. PubMed ID: 33589525
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells.
    Feng PH, Lam B, Tseng SH, Kung YJ, Farmer E, Cheng MA, Hung CF.
    Cancer Immunol Immunother; 2020 Oct 01; 69(10):2147-2155. PubMed ID: 32468232
    [Abstract] [Full Text] [Related]

  • 10. Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer.
    Hu P, Arias RS, Sadun RE, Nien YC, Zhang N, Sabzevari H, Lutsiak ME, Khawli LA, Epstein AL.
    Clin Cancer Res; 2008 Jan 15; 14(2):579-88. PubMed ID: 18223234
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment.
    Budhu S, Schaer DA, Li Y, Toledo-Crow R, Panageas K, Yang X, Zhong H, Houghton AN, Silverstein SC, Merghoub T, Wolchok JD.
    Sci Signal; 2017 Aug 29; 10(494):. PubMed ID: 28851824
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity.
    Akimova T, Wang L, Bartosh Z, Christensen LM, Eruslanov E, Singhal S, Aishwarya V, Hancock WW.
    Front Immunol; 2024 Aug 29; 15():1426657. PubMed ID: 39234236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.